Phase III clinical trials (Clinical trial)

Harmony Acquiring Zynerba, a Leader in Development of Cannabioid-Based Gel
News & Features

Harmony Acquiring Zynerba, a Leader in Development of Cannabioid-Based Gel

Malorye Branca -
0
Are We Nearly There Yet?
News & Features

Are We Nearly There Yet?

Kathy Vuksanaj -
0
Charging to the Frontline
News & Features

Charging to the Frontline

Chris Anderson -
0
Lilly’s Retevmo Beats PD-1 Combo for RET Fusion-Positive Lung Cancer
News & Features

Lilly’s Retevmo Beats PD-1 Combo for RET Fusion-Positive Lung Cancer

Alisa Kirkin -
0
First-line Atezolizumab Improves Survival in Platinum-Ineligible NSCLC
News & Features

First-line Atezolizumab Improves Survival in Platinum-Ineligible NSCLC

Chris Anderson -
0
New Regimen Improves Graft-Versus-Host Disease Response
News & Features

New Regimen Improves Graft-Versus-Host Disease Response

Malorye Branca -
0
Home-Based HPV Testing Boosts Cervical Screening Uptake among Under-Screened Women
Molecular Dx

Home-Based HPV Testing Boosts Cervical Screening Uptake among Under-Screened Women

Chris Anderson -
0
Bone Biomarkers Linked to Prostate Cancer Survival
News & Features

Bone Biomarkers Linked to Prostate Cancer Survival

Helen Albert -
0
Lilly’s Donanemab Shines in Phase III for Alzheimer’s
News & Features

Lilly’s Donanemab Shines in Phase III for Alzheimer’s

Malorye Branca -
2
Pragmatica-Lung Study Aims to Streamline Cancer Trials
News & Features

Pragmatica-Lung Study Aims to Streamline Cancer Trials

Malorye Branca -
0
123Page 1 of 3

Related Content

Copyright © 2023 Genetic Engineering & Biotechnology News. All Rights Reserved.
Inside Precision Medicine